Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Melanoma × cobimetinib × Clear all

Status

Sponsor Class

Study Type

Interventional 28 Observational 1

Sponsor

Cancer Type

Conditions

Interventions

Blood Specimen Collection 12 Nivolumab 11 Ipilimumab 11 pembrolizumab 10 Surveys and Questionnaires 8 trametinib 7 Gene Expression Profiling 7 dabrafenib 6 Biopsy 5 Specimen Handling 4 Immunotherapy 4 Amplified Fragment Length Polymorphism Analysis 4 atezolizumab 3 Restraint, Physical 3 Introns 3 Immunohistochemistry 3 tremelimumab 2 aldesleukin 2 Watchful Waiting 2 Therapeutics 2 Surgical Procedures, Operative 2 Polymerase Chain Reaction 2 Methods 2 Magnetic Resonance Spectroscopy 2 Liquid Biopsy 2 Interferon-alpha 2 Histocompatibility Testing 2 Flow Cytometry 2 Drug Therapy 2 Diagnostic Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03139513 2019-01-22

MELANIS

Hoffmann-La Roche

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡